These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1385 related items for PubMed ID: 8784084

  • 41. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW, Lau KS, Kohn LD.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [Abstract] [Full Text] [Related]

  • 42. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM, Lima N, Knobel M, Cavaliere H, Medeiros-Neto G.
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [Abstract] [Full Text] [Related]

  • 43. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A, Yamada T, Aizawa T, Ichikawa K, Komiya I, Takasu N, Takemura Y.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [Abstract] [Full Text] [Related]

  • 44. Effect of thyroxine administration on serum thyrotropin receptor antibody and thyroglobulin levels in patients with Graves' hyperthyroidism during antithyroid drug therapy.
    Kuo SW, Huang WS, Hu CA, Liao WK, Fung TC, Wu SY.
    Eur J Endocrinol; 1994 Aug; 131(2):125-30. PubMed ID: 8075781
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Changes in thyrotropin receptor antibody after subtotal thyroidectomy in Graves' disease: comparison with the degree of lymphocytic infiltration in the thyroid.
    Cho BY, Oh SK, Shong YK, Kim SE, Yoo HY, Lee HK, Koh CS, Min HK.
    Autoimmunity; 1990 Aug; 8(2):143-7. PubMed ID: 1983330
    [Abstract] [Full Text] [Related]

  • 48. [Correlation between thyroid stimulating immunoglobulins and thyrotropin binding inhibitory immunoglobulins levels in patients with Graves' disease].
    Jonas M, Ambroziak U, Nauman J.
    Endokrynol Pol; 2006 Aug; 57(1):23-30. PubMed ID: 16575759
    [Abstract] [Full Text] [Related]

  • 49. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [Abstract] [Full Text] [Related]

  • 50. Detection of low titre TBII in patients with Graves' disease using recombinant human TSH receptor.
    Morgenthaler NG, Nagata A, Katayama S, Bergmann A, Iitaka M.
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):193-8. PubMed ID: 12153597
    [Abstract] [Full Text] [Related]

  • 51. High prevalence and little change in TSH receptor blocking antibody titres with thyroxine and antithyroid drug therapy in patients with non-goitrous autoimmune thyroiditis.
    Cho BY, Kim WB, Chung JH, Yi KH, Shong YK, Lee HK, Koh CS.
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):465-71. PubMed ID: 7586622
    [Abstract] [Full Text] [Related]

  • 52. The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs.
    Michelangeli V, Poon C, Taft J, Newnham H, Topliss D, Colman P.
    Thyroid; 1998 Feb; 8(2):119-24. PubMed ID: 9510119
    [Abstract] [Full Text] [Related]

  • 53. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
    Woo YJ, Jang SY, Lim TH, Yoon JS.
    Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
    [Abstract] [Full Text] [Related]

  • 54. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG, Ho SC, Minich WB.
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [Abstract] [Full Text] [Related]

  • 55. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C, Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Nersita R, Iorio S, Amato G, Braverman LE, Roti E.
    Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
    [Abstract] [Full Text] [Related]

  • 56. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM, Schimmel M, Utiger RD.
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [Abstract] [Full Text] [Related]

  • 57. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
    Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Tørring O.
    Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
    [Abstract] [Full Text] [Related]

  • 58. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H, Kasagi K, Morita T, Hidaka A, Kuma K, Konishi J, Kumagai LF, Nagataki S.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [Abstract] [Full Text] [Related]

  • 59. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH, Eng PH, Ho SC, Tai ES, Morgenthaler NG, Seah LL, Fong KS, Chee SP, Choo CT, Aw SE.
    Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
    [Abstract] [Full Text] [Related]

  • 60. [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy].
    Heberling HJ, Bierwolf B, Kuhlmann E, Klugmann T, Dietel P, Fischer S.
    Dtsch Z Verdau Stoffwechselkr; 1987 Dec; 47(6):331-6. PubMed ID: 2896115
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 70.